Movement disorders and psychosis, a complex marriage

Frontiers in Psychiatry

Volumn 6, Issue JAN, 2015, Pages

  Van Harten, Peter N ^a,b   Bakker, P Roberto ^a,b   Mentzel, Charlotte L ^a,b   Tijssen, Marina A ^c   Tenback, Diederik E ^a,c  

^a Psychiatric Centre GGZ Centraal   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Instrumental assessment; Movement disorders; Psychotic disorders; Schizophrenia; Tardive dyskinesia

Indexed keywords

CLOZAPINE; DOPAMINE RECEPTOR BLOCKING AGENT; METOCLOPRAMIDE; NEUROLEPTIC AGENT;

AKATHISIA; ARTICLE; BASAL GANGLION; BEHAVIOR DISORDER; BRADYKINESIA; COGNITIVE DEFECT; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; DYSKINESIA; DYSTONIA; EMOTIONAL DISORDER; HUMAN; IMPULSE CONTROL DISORDER; INSOMNIA; META ANALYSIS (TOPIC); MOTOR DYSFUNCTION; NAUSEA; NEUROLOGIC DISEASE; PARKINSONISM; PATHOPHYSIOLOGY; PSYCHOSIS; RISK ASSESSMENT; SCHIZOPHRENIA; SCREENING; TARDIVE DYSKINESIA;

EID: 84926651821     PISSN: None     EISSN: 16640640     Source Type: Journal    
DOI: 10.3389/fpsyt.2014.00190     Document Type: Article

References (38)

1. Bleuler E. Lehrbuch der Psychiatrie. Berlin: Springer (1916).
2. Tarbox SI, Pogue-Geile MF. Spontaneous dyskinesia and familial liability to schizophrenia. Schizophr Res (2006) 81:125-37. doi:10.1016/j.schres.2005.09.013
3. McCreadie RG, Padmavati R, Thara R, Srinivasan TN. Spontaneous dyskinesia and parkinsonism in never-medicated, chronically ill patients with schizophrenia: 18-month follow-up. Br J Psychiatry (2002) 181:135-7. doi:10.1192/bjp.181.2.135
4. Fenton WS. Prevalence of spontaneous dyskinesia in schizophrenia. J Clin Psychiatry (2000) 61(Suppl 4):10-4. doi:10.1002/mds.23050
5. Koning JP, Tenback DE, van Os J, Aleman A, Kahn RS, van Harten PN. Dyskinesia and parkinsonism in antipsychotic-naive patients with schizophrenia, first-degree relatives and healthy controls: a meta-analysis. Schizophr Bull (2010) 36:723-31. doi:10.1093/schbul/sbn146
6. Bervoets C, Docx L, Sabbe B, Vermeylen S, Van Den Bossche MJ, Morsel A, et al. The nature of the relationship of psychomotor slowing with negative symptomatology in schizophrenia. Cogn Neuropsychiatry (2014) 19:36-46. doi:10.1080/13546805.2013.779578
7. Morrens M, Hulstijn W, Sabbe B. Psychomotor slowing in schizophrenia. Schizophr Bull (2007) 33:1038-53. doi:10.1093/schbul/sbl051
8. Walther S, Strik W. Motor symptoms and schizophrenia. Neuropsychobiology (2012) 66:77-92. doi:10.1159/000339456
9. Cuesta MJ, Sanchez-Torres AM, de Jalon EG, Campos MS, Ibanez B, Moreno-Izco L, et al. Spontaneous parkinsonism is associated with cognitive impairment in antipsychotic-naive patients with first-episode psychosis: a 6-month follow-up study. Schizophr Bull (2014) 40:1164-73. doi:10.1093/schbul/sbt125
10. Peralta V, de Jalon EG, Campos MS, Cuesta MJ. Phenomenological differences between spontaneous and drug-related extrapyramidal syndromes in patients with schizophrenia-spectrum disorders. J Clin Psychopharmacol (2013) 33:438-40. doi:10.1097/JCP.0b013e31828f62b0
11. Whitty PF, Owoeye O, Waddington JL. Neurological signs and involuntary movements in schizophrenia: intrinsic to and informative on systems pathobiology. Schizophr Bull (2009) 35:415-24. doi:10.1093/schbul/sbn126
12. Jeste DV, Caligiuri MP, Paulsen JS, Heaton RK, Lacro JP, Harris MJ, et al. Risk of tardive dyskinesia in older patients. A prospective longitudinal study of 266 outpatients. Arch Gen Psychiatry (1995) 52:756-65. doi:10.1001/archpsyc.1995.03950210050010
13. Dolder CR, Jeste DV. Incidence of tardive dyskinesia with typical versus atypical antipsychotics in very high risk patients. Biol Psychiatry (2003) 53:1142-5. doi:10.1016/S0006-3223(03)00170-7
14. van Harten PN, Matroos GE, Hoek HW, Kahn RS. The prevalence of tardive dystonia, tardive dyskinesia, parkinsonism and akathisia: the Curacao extrapyramidal syndromes study: I. Schizophr Res (1996) 19:195-203. doi:10.1016/0920-9964(95)00096-8
15. van Harten PN, Hoek HW, Matroos GE, van Os J. Incidence of tardive dyskinesia and tardive dystonia in African Caribbean patients on long-term antipsychotic treatment: the Curacao extrapyramidal syndromes study V. J Clin Psychiatry (2006) 67:1920-7. doi:10.4088/JCP.v67n1212
16. Koning JP, Kahn RS, Tenback DE, van Schelven LJ, van Harten PN. Movement disorders in nonpsychotic siblings of patients with nonaffectivepsychosis. Psychiatry Res (2011) 188:133-7. doi:10.1016/j.psychres.2011.01.005
17. Cortese L, Caligiuri MP, Malla AK, Manchanda R, Takhar J, Haricharan R. Relationship of neuromotor disturbances to psychosis symptoms in first-episode neuroleptic-naive schizophrenia patients. Schizophr Res (2005) 75:65-75. doi:10.1016/j.schres.2004.08.003
18. Rao AS, Camilleri M. Review article: metoclopramide and tardive dyskinesia. Aliment Pharmacol Ther (2010) 31:11-9. doi:10.1111/j.1365-2036.2009.04189.x
19. Anderson SL, Vande Griend JP. Quetiapine for insomnia: a review of the literature. Am J Health Syst Pharm (2014) 71:394-402. doi:10.2146/ajhp130221
20. Mahmoudi S, Levesque D, Blanchet PJ. Upregulation of dopamine D3, not D2, receptors correlates with tardive dyskinesia in a primate model. Mov Disord (2014) 29:1125-33. doi:10.1002/mds.25909
21. Bergman H, Kimura M, Wickens JR. Modulation of striatal circuits by dopamine and acetylcholine. In: Grillner S, Graybiel AM, editors. Microcircuits: The Interface Between Neurons and Global Brain Function. Cambridge: The MIT Press (2006). p. 149-63.
22. Mitterauer B. Pathophysiology of schizophrenia based on impaired glial-neuronal interactions. Open J Med Psychol (2014) 3:126-40. doi:10.4236/ojmp.2014.32016
23. Silvestri S, Seeman MV, Negrete JC, Houle S, Shammi CM, Remington GJ, et al. Increased dopamine D2 receptor binding after long-term treatment with antipsychotics in humans: a clinical PET study. Psychopharmacology (Berl) (2000) 152:174-80. doi:10.1007/s002130000532
24. Mittal VA, Walker EF. Movement abnormalities predict conversion to axis I psychosis among prodromal adolescents. J Abnorm Psychol (2007) 116:796-803. doi:10.1037/0021-843X.116.4.796
25. Mittal VA, Tessner KD, Trottman HD, Esterberg M, Dhrub SH, Simeonova DI, et al. Movement abnormalities and the progression of prodromal symptomatology in adolescents at risk for psychotic disorders. J Abnorm Psychol (2007) 116:260-7. doi:10.1037/0021-843X.116.2.260
26. van der Gaag M, Smit F, Bechdolf A, French P, Linszen DH, Yung AR, et al. Preventing a first episode of psychosis: meta-analysis of randomized controlled prevention trials of 12 month and longer-term follow-ups. Schizophr Res (2013) 149:56-62. doi:10.1016/j.schres.2013.07.004
27. Obeso JA, Rodriguez-Oroz MC, Stamelou M, Bhatia KP, Burn DJ. The expanding universe of disorders of the basal ganglia. Lancet (2014) 384:523-31. doi:10.1016/S0140-6736(13)62418-6
28. Tenback DE. An Epidemiological Approach to Elucidate Doapminergic Mechanism in Tardive Dyskinesia in Schizophrenia. Maastricht: Maastricht University (2006).
29. Waddington JL, Youssef HA. Cognitive dysfunction in chronic schizophrenia followed prospectively over 10 years and its longitudinal relationship to the emergence of tardive dyskinesia. Psychol Med (1996) 26:681-8. doi:10.1017/S0033291700037697
30. Tenback DE, van Harten PN, Slooff CJ, van Os J. Evidence that early extrapyramidal symptoms predict later tardive dyskinesia: a prospective analysis of 10,000 patients in the European Schizophrenia Outpatient Health Outcomes (SOHO) study. Am J Psychiatry (2006) 163:1438-40. doi:10.1176/appi.ajp.163.8.1438
31. Bakker PR, van Harten PN, van Os J. Antipsychotic-induced tardive dyskinesia and polymorphic variations in COMT, DRD2, CYP1A2 and MnSOD genes: a meta-analysis of pharmacogenetic interactions. Mol Psychiatry (2008) 13(5):544-56. doi:10.1038/sj.mp.4002142
32. Rizos A, Martinez-Martin P, Odin P, Antonini A, Kessel B, Kozul TK, et al. Characterizing motor and non-motor aspects of early-morning off periods in Parkinson's disease: an international multicenter study. Parkinsonism Relat Disord (2014) 20(11): 1231-5. doi:10.1016/j.parkreldis.2014.09.013
33. Koning JP, Tenback DE, Kahn RS, Van Schelven LJ, Van Harten PN. Instrument measurement of lingual force variability reflects tardive tongue dyskinesia. J Med Eng Technol (2010) 34:71-7. doi:10.3109/03091900903402105
34. Dean DJ, Teulings HL, Caligiuri M, Mittal VA. Handwriting analysis indicates spontaneous dyskinesias in neuroleptic naive adolescents at high risk for psychosis. J Vis Exp (2013) 81:e50852. doi:10.3791/50852
35. Caligiuri MP, Teulings HL, Dean CE, Niculescu AB, Lohr J. Handwriting movement analyses for monitoring drug-induced motor side effects in schizophrenia patients treated with risperidone. Hum Mov Sci (2009) 28:633-42. doi:10.1016/j.humov.2009.07.007
36. Dean CE, Russell JM, Kuskowski MA, Caligiuri MP, Nugent SM. Clinical rating scales and instruments: how do they compare in assessing abnormal, involuntary movements? J Clin Psychopharmacol (2004) 24:298-304. doi:10.1097/01.jcp.0000125681.97466.e7
37. Docx L, Sabbe B, Provinciael P, Merckx N, Morrens M. Quantitative psychomotor dysfunction in schizophrenia: a loss of drive, impaired movement execution or both? Neuropsychobiology (2013) 68:221-7. doi:10.1159/000355293
38. Morrens M, Docx L, Walther S. Beyond boundaries: in search of an integrative view on motor symptoms in schizophrenia. Front Psychiatry (2014) 5:145. doi:10.3389/fpsyt.2014.00145